๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

M.P.4.05 Randomized placebo controlled double blind pilot trial of Ramipril in McArdle disease patients

โœ Scribed by A. Liava; E. Trevisi; M. Frare; C. Tonon; E. Malucelli; D. Manners; G. Kemp; C. Testa; B. Barbiroli; R. Lodi; A. Martinuzzi


Book ID
116793179
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
59 KB
Volume
17
Category
Article
ISSN
0960-8966

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Randomized, placebo-controlled, double-b
โœ Andrea Martinuzzi; Alexandra Liava; Enrico Trevisi; Mara Frare; Caterina Tonon; ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 182 KB

## Abstract McArdle's disease causes limitation in exercise capacity as well as disability, the severity of which has been associated with the angiotensinโ€converting enzyme (ACE) insertion (I)/deletion (D) haplotypeโ€”patients with the genotype associated with higher ACE activity show the most severe

A randomized, double-blind, placebo-cont
โœ Kitty K. Wong; Jane E. Alty; Amanda G. Goy; Sanjay Raghav; David C. Reutens; Pet ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 565 KB

## Abstract ## Background: This randomized double blind, placeboโ€controlled crossover study investigated the antidyskinetic effects of levetiracetam in Parkinson's disease. ## Methods: Sixteen participants with levodopaโ€induced dyskinesia were enrolled. Hourly videotaped dyskinesia assessments s